Personal tools

Coexpression cluster:C1685: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C1685_immature_CD14_Eosinophils_CD34_migratory_lymphoma_Neutrophils |id=C1685 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C1685_immature_CD14_Eosinophils_CD34_migratory_lymphoma_Neutrophils
|full_id=C1685_immature_CD14_Eosinophils_CD34_migratory_lymphoma_Neutrophils
|id=C1685
|id=C1685
|ontology_enrichment_celltype=CL:0000738!1.10e-54!140;CL:0000037!3.33e-48!172;CL:0000566!3.33e-48!172;CL:0002032!2.10e-45!165;CL:0000837!2.10e-45!165;CL:0000988!5.32e-44!182;CL:0002031!2.72e-43!124;CL:0002087!4.04e-42!119;CL:0000766!8.19e-34!76;CL:0000557!1.55e-30!71;CL:0000763!2.50e-29!112;CL:0000049!2.50e-29!112;CL:0000839!1.22e-27!70;CL:0002009!2.69e-27!65;CL:0002194!5.73e-26!63;CL:0000576!5.73e-26!63;CL:0000040!5.73e-26!63;CL:0000559!5.73e-26!63;CL:0002057!2.09e-25!42;CL:0000860!5.06e-25!45;CL:0000542!4.22e-14!53;CL:0000051!4.22e-14!53;CL:0000838!8.86e-14!52;CL:0000945!2.68e-08!24;CL:0000826!2.68e-08!24;CL:0000451!1.75e-07!10
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!3.64e-32!102;UBERON:0003061!3.64e-32!102;UBERON:0002193!1.21e-31!112;UBERON:0002371!3.52e-24!80;UBERON:0001474!4.83e-23!86;UBERON:0002405!1.60e-21!115;UBERON:0004765!1.03e-16!101;UBERON:0001434!1.03e-16!101;UBERON:0007023!6.41e-08!115
}}
}}

Revision as of 14:14, 21 May 2012


Full id: C1685_immature_CD14_Eosinophils_CD34_migratory_lymphoma_Neutrophils



Phase1 CAGE Peaks

Hg19::chr12:72148728..72148739,+p3@RAB21
Hg19::chr2:61108695..61108753,+p1@REL
Hg19::chr2:61108771..61108789,+p4@REL
Hg19::chr2:61108808..61108821,+p3@REL
Hg19::chr2:61118914..61118929,+p1@AB464350


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
leukocyte1.10e-54140
hematopoietic stem cell3.33e-48172
angioblastic mesenchymal cell3.33e-48172
hematopoietic oligopotent progenitor cell2.10e-45165
hematopoietic multipotent progenitor cell2.10e-45165
hematopoietic cell5.32e-44182
hematopoietic lineage restricted progenitor cell2.72e-43124
nongranular leukocyte4.04e-42119
myeloid leukocyte8.19e-3476
granulocyte monocyte progenitor cell1.55e-3071
myeloid cell2.50e-29112
common myeloid progenitor2.50e-29112
myeloid lineage restricted progenitor cell1.22e-2770
macrophage dendritic cell progenitor2.69e-2765
monopoietic cell5.73e-2663
monocyte5.73e-2663
monoblast5.73e-2663
promonocyte5.73e-2663
CD14-positive, CD16-negative classical monocyte2.09e-2542
classical monocyte5.06e-2545
lymphocyte4.22e-1453
common lymphoid progenitor4.22e-1453
lymphoid lineage restricted progenitor cell8.86e-1452
lymphocyte of B lineage2.68e-0824
pro-B cell2.68e-0824
dendritic cell1.75e-0710
Uber Anatomy
Ontology termp-valuen
hematopoietic system3.64e-32102
blood island3.64e-32102
hemolymphoid system1.21e-31112
bone marrow3.52e-2480
bone element4.83e-2386
immune system1.60e-21115
skeletal element1.03e-16101
skeletal system1.03e-16101
adult organism6.41e-08115


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.